Another important thing to consider prior to placing where to buy tadalafil Foreplay is the section of sensuous sex levitra buy Somebody who is sexually very active and content means he can stay a very long and healthy lifestyle. It buy levitra no prescription Known as sildenafil citrate, tadalafil, and vardenafil how to buy generic viagra online This vardenafil is accessible both in manufacturers together with under common goods. Cheap Levitra is found under generic products and generic levitra 10mg Additionally, Vardenafil have also shown to be very effective in all age groups, and is buy levitra online no prescription All the products is fighting in the same marketplace as Viagra and in order to boost their market can i buy viagra at cvs Kamagra is a generic form of the non-classical have Viagra, dependability and device is the duplicate with its manufacturer vardenafil 20 mg The fundamental contents of the formula making endurance-RX are gamma-aminobutyric Acid, Cnidium Monnier L-Arginine, Xanthoparmelia Scabrosa and buy pfizer viagra online Presently, the financials policies of Vardenafil also indicate that Levitra on line can be availed of by generic levitra 60mg

Uncategorized

CaverStem® Adult Stem Cell Therapy For Erectile Dysfunction Receives Positive Reception At International Urology Conference

PHOENIX, May 23, 2018 /PRNewswire/ — Creative Medical Technology Holdings (OTCQB:CELZ) announced today completion of its 3 day exhibition at the American Urology Association (AUA) meeting. The Company’s presentations where delivered by Dr. Alexander Gershman, Director of The Institute of Advanced Urology at the Cedars-Sinai Medical Tower; Director of Urologic Laparoscopy in the Division of …

CaverStem® Adult Stem Cell Therapy For Erectile Dysfunction Receives Positive Reception At International Urology Conference Read More »

“Urologist to the Stars” Dr. Alexander Gershman to attend American Urological Association conference to discuss the CaverStem® Stem Cell Procedure for Drug Refractory Erectile Dysfunction

PHOENIX and LOS ANGELES, May 8, 2018 /PRNewswire/ — Creative Medical Technology Holdings Inc. (OTCQB ticker symbol CELZ) announced today that Dr. Alexander Gershman will attend the AUA conference on May 19th and 20th with Creative Medical Technology Holdings, Inc. to discuss the CaverStem® procedure from the perspective of a physician treating patients. Dr. Alexander Gershman, …

“Urologist to the Stars” Dr. Alexander Gershman to attend American Urological Association conference to discuss the CaverStem® Stem Cell Procedure for Drug Refractory Erectile Dysfunction Read More »

Creative Medical Technology Holdings, Inc. To Unveil Its Patented CaverStem® Procedure For Erectile Dysfunction At International Urology Conference

PHOENIX, March 26, 2018 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) will be exhibiting it’s patented CaverStem® stem cell procedure for erectile dysfunction at the annual American Urological Association (AUA) conference on May 18-21, 2018 in San Francisco. According to the AUA “Last year’s meeting welcomed more than 16,000 attendees from more than 100 …

Creative Medical Technology Holdings, Inc. To Unveil Its Patented CaverStem® Procedure For Erectile Dysfunction At International Urology Conference Read More »

Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy

Collaboration between Stem Cell Clinician, Neurologist, and Cell Therapy Developer Results in Novel Regenerative Approach to Stroke PHOENIX and SAN DIEGO, Dec. 13, 2016 /PRNewswire/ — Creative Medical Technology Holdings (the “Company”) (OTCQB:CELZ) announced today filing of US patent application #62/400557 entitled “Treatment of Stroke by Amniotic Fluid Derived Stem Cell Conditioned Media and Products Derived Thereof.” The …

Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy Read More »

Creative Medical Technology Holdings Recruits Internationally Renowned Neurologist to Assist in Clinical Development of AmnioStem Stem Cell Therapy for Stroke

Clinical Stage Stem Cell Therapeutics Company Aims to Develop “Universal Donor” Stem Cell “Drug” for Stroke Patients PHOENIX and SAN DIEGO, Dec. 6, 2016 /PRNewswire/ — Creative Medical Technology Holdings (OTCQB:CELZ) announced the appointment of Santosh Kesari, MD, PhD, FANA, FAAN to the Company’s Scientific Advisory Board. Dr. Kesari will leverage his experience in neurology and clinical trials to assist the Company’s …

Creative Medical Technology Holdings Recruits Internationally Renowned Neurologist to Assist in Clinical Development of AmnioStem Stem Cell Therapy for Stroke Read More »

Creative Medical Technology Holdings Announces Creation of Amniotic Fluid Stem Cell Focused Subsidiary AmnioStem LLC

Clinical Stage Stem Cell Therapeutics Company Expands Regenerative Medicine Portfolio to ‘Off-the-Shelf’ Allogeneic Stem Cell Products PHOENIX, Nov. 16, 2016 /PRNewswire/ — Creative Medical Technology Holdings (OTCQB:CELZ) announced today the formation of a wholly-owned subsidiary, AmnioStem LLC, focused on the development of therapeutic products derived from amniotic fluid stem cells. These stem cells are subject …

Creative Medical Technology Holdings Announces Creation of Amniotic Fluid Stem Cell Focused Subsidiary AmnioStem LLC Read More »

Creative Medical Technologies Receives Exclusive License to Key Amniotic Fluid Stem Cell Patent from University of California System

Patent Rights Cover Multipotent Amniotic Fetal Stem Cells PHOENIX, Nov. 2, 2016 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (OTCQB:CELZ) announced today signing of an exclusive license agreement with the University of California System to commercialize and develop a novel type of amniotic fluid derived stem cell as disclosed in issued US Patent No. 7,569,385. …

Creative Medical Technologies Receives Exclusive License to Key Amniotic Fluid Stem Cell Patent from University of California System Read More »

Creative Medical Technology Holdings, Inc. Recruits Internationally Renowned Urologic Surgery Pioneer Dr. Alexander Gershman to Scientific Advisory Board

Clinical Stage Company Developing Stem Cell Therapy for Treatment-Refractory Erectile Dysfunction Recruits “Doctor to the Stars” PHOENIX, Nov. 1, 2016 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (OTCQB: CELZ) announced today appointment of Alexander Gershman, MD, Ph.D to the company’s Scientific Advisory Board. Dr. Gershman is an internationally-renowned opinion leader in urological surgery having pioneered …

Creative Medical Technology Holdings, Inc. Recruits Internationally Renowned Urologic Surgery Pioneer Dr. Alexander Gershman to Scientific Advisory Board Read More »

Creative Medical Technology Holdings Expands Adult Stem Cell Therapeutic Platform to Combat Female Infertility Caused by Premature Ovarian Failure

Company Files Patent on Rejuvenating Ovaries through Use of Endothelial Progenitor Cell Stem Cells PHOENIX, Aug. 24, 2016 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (OTCQB: CELZ) announced the filing of a patent application disclosing means of regenerating failing ovaries through use of a particular type of stem cell extracted from patient’s own tissues. The …

Creative Medical Technology Holdings Expands Adult Stem Cell Therapeutic Platform to Combat Female Infertility Caused by Premature Ovarian Failure Read More »

Creative Medical Technologies Completes Proof-of-Concept Studies at Preventing Miscarriages Using Stem Cell Immunotherapy

Clinical Stage Erectile Dysfunction Company Expands Product Pipeline into Reproductive Immunology PHOENIX, June 21, 2016 /PRNewswire/ — Creative Medical Technologies (OTCQB: CELZ) announced today filing of a patent application containing novel data suggesting that specialized cells obtained from adipose (fat) tissue are capable of preventing recurrent miscarriages in an animal model. These data support the …

Creative Medical Technologies Completes Proof-of-Concept Studies at Preventing Miscarriages Using Stem Cell Immunotherapy Read More »